The Group's principal activity is to develop, manufacture & market point-of-care rapid diagnostics for detection of human medical conditions & illness. The products of the Group are pregnancy, infectious diseases, osteoporosis & urinalysis. Quidel focuses its products substantially on women's & family health in areas, such as reproduction, infectious diseases, general health & diseases associated with the elderly. The products include QuickVue, QuickVue+, FemExam. The major customers of the Group include Cardinal Healthcare Corporation, Sumitomo Seiyaku Biomedical Co Ltd & McKesson Corporation. Group develop research products through our Specialty Products Group. The SPG is currently responsible for more than 100 research products used worldwide. It operates in Asia, Europe and United States of America.
Alacra Alerts:
Receive alerts on the latest reports on Quidel Corporation
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
